HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea · Delayed Price · Currency is KRW 3,280.00
-60.00 (-1.80%)
Oct 29, 2026, 3:30 PM KST
HLB Life Science Market Cap
HLB Life Science has a market cap or net worth of 399.66 billion as of October 28, 2026. It is the 18,065th most valuable company in the world and the 515th biggest in South Korea. Its market cap has decreased by 23.36% in one year.
Market Cap
399.66B
Enterprise Value
544.73B
Revenue
54.40B
Global Rank
Country Rank
#515 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2008, HLB Life Science's market cap has increased from 12.28B to 399.66B, an increase of 3,153.83%. That is a compound annual growth rate of 21.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 399.66B | -15.35% |
| Dec 30, 2025 | 472.16B | -61.28% |
| Dec 30, 2024 | 1.22T | 4.61% |
| Dec 28, 2023 | 1.17T | 8.14% |
| Dec 29, 2022 | 1.08T | -9.34% |
| Dec 30, 2021 | 1.19T | -7.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.53T |
| Celltrion | 43.08T |
| ALTEOGEN | 15.21T |
| Samsung Epis Holdings | 7.75T |
| i-SENS | 452.34B |
| Medy-Tox | 435.93B |
| AbClon | 420.99B |
| GC Corp. | 410.33B |